Prostate Cancer Daily

November 01, 2024

Videos

Peer-to-Peer Clinical Conversations

Challenges in Transitioning Men from Active Surveillance to Watchful Waiting - Lisa Lowenstein

Lisa Lowenstein

Zachary Klaassen speaks with Lisa Lowenstein about transitioning men from active surveillance to watchful waiting in prostate cancer management.

Advancements in Lutetium-PSMA Therapy for Prostate Cancer: Clinical Trials and Future Directions - Ken Herrmann

Ken Herrmann

Oliver Sartor and Ken Herrmann discuss the current state and future directions of PSMA ligand therapy in prostate cancer treatment.

Beyond the Abstracts

How Can We Identify Extraprostatic Extension (EPE) Before Surgery? the Use of a Preoperative Prostate MRI EPE Scoring System to Assess Post-Prostatectomy Locally Advanced Prostate Cancer - Beyond the Abstract

The Added Value of Side-specific Systematic Biopsy in Patients Diagnosed by Magnetic Resonance Imaging-targeted Prostate Biopsy - Beyond the Abstract

Conference Coverage

SCS AUA 2024: Clinical Trial Updates for Treatment of Metastatic Prostate Cancer

SCS AUA 2024: Focal Therapy in Prostate Cancer

SCS AUA 2024: Transitioning Men to Watchful Waiting

SCS AUA 2024: Active Surveillance for Low Volume Gleason Grade Group 2 Disease: Con

SCS AUA 2024: Active Surveillance for Intermediate Risk Prostate Cancer

Articles

Editor Selected Abstracts and Commentaries

Prostate Cancer

Adiposity and Muscle Strength in Men With Prostate Cancer and Cardiovascular Outcomes.

PSMA PET/CT Accuracy in Diagnosing Prostate Cancer Nodes Metastases.

Outcomes for Patients with Metastatic Castration-Resistant Prostate Cancer and Liver Metastasis Receiving [177Lu]Lu-PSMA-617.

Comparison of Posttherapy 4- and 24-Hour [177Lu]Lu-PSMA SPECT/CT and Pretherapy PSMA PET/CT in Assessment of Disease in Men with Metastatic Castration-Resistant Prostate Cancer.

FAP and PSMA Expression by Immunohistochemistry and PET Imaging in Castration-Resistant Prostate Cancer: A Translational Pilot Study.

Clinical, Pathologic, and Imaging Variables Associated with Prostate Cancer Detection by PSMA PET/CT and Multiparametric MRI.

A Phase I Trial of Image-Guided, Risk-Volume-Adapted Post-Prostatectomy Radiotherapy - Beyond the Abstract

CONNECT WITH US

Questions or Comments? Email us at editors@urotoday.com

Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523

You are receiving this email because you have chosen to receive emails from UroToday.

Add us to your address book View this email as a web page Forward to a colleague Manage your subscriptions Unsubscribe

Copyright ©2024 Digital Science Press, LLC